Kim K - Search Results

1

The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer.

Kim K, Khazan N, McDowell JL, Snyder CWA, Miller JP, Singh RK, Whittum ME, Turner R, Moore RG. Kim K, et al. PLoS One. 2024 Dec 2;19(12):e0314564. doi: 10.1371/journal.pone.0314564. eCollection 2024. PLoS One. 2024. PMID: 39621651 Free PMC article.

2

HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.

Ribeiro JR, Schorl C, Yano N, Romano N, Kim KK, Singh RK, Moore RG. Ribeiro JR, et al. Among authors: kim kk. J Ovarian Res. 2016 May 17;9(1):28. doi: 10.1186/s13048-016-0240-0. J Ovarian Res. 2016. PMID: 27184254 Free PMC article.

3

Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines.

Kim KK, Singh RK, Khazan N, Kodza A, Singh NA, Jones A, Sivagnanalingam U, Towner M, Itamochi H, Turner R, Moore RG. Kim KK, et al. Sci Rep. 2020 Feb 24;10(1):3241. doi: 10.1038/s41598-020-59824-4. Sci Rep. 2020. PMID: 32094384 Free PMC article.

4

Role of trypsin and protease-activated receptor-2 in ovarian cancer.

Kim KK, Turner R, Khazan N, Kodza A, Jones A, Singh RK, Moore RG. Kim KK, et al. PLoS One. 2020 May 4;15(5):e0232253. doi: 10.1371/journal.pone.0232253. eCollection 2020. PLoS One. 2020. PMID: 32365084 Free PMC article.

5

HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression.

Rowswell-Turner RB, Singh RK, Urh A, Yano N, Kim KK, Khazan N, Pandita R, Sivagnanalingam U, Hovanesian V, James NE, Ribeiro JR, Kadambi S, Linehan DC, Moore RG. Rowswell-Turner RB, et al. Among authors: kim kk. J Immunol. 2021 May 15;206(10):2478-2488. doi: 10.4049/jimmunol.2000281. Epub 2021 Apr 26. J Immunol. 2021. PMID: 33903172

6

Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumors.

Blackman A, Mitchell J, Rowswell-Turner R, Singh R, Kim KK, Eklund E, Skates S, Bast RC, Messerlian G, Miller MC, Moore RG. Blackman A, et al. Tumour Biol. 2021;43(1):355-365. doi: 10.3233/TUB-211546. Tumour Biol. 2021. PMID: 34957977 Free article.

7

Iron(III)-salophene: an organometallic compound with selective cytotoxic and anti-proliferative properties in platinum-resistant ovarian cancer cells.

Lange TS, Kim KK, Singh RK, Strongin RM, McCourt CK, Brard L. Lange TS, et al. Among authors: kim kk. PLoS One. 2008 May 28;3(5):e2303. doi: 10.1371/journal.pone.0002303. PLoS One. 2008. PMID: 18509533 Free PMC article.

8

Organometallic iron(III)-salophene exerts cytotoxic properties in neuroblastoma cells via MAPK activation and ROS generation.

Kim KK, Singh RK, Strongin RM, Moore RG, Brard L, Lange TS. Kim KK, et al. PLoS One. 2011 Apr 29;6(4):e19049. doi: 10.1371/journal.pone.0019049. PLoS One. 2011. PMID: 21559503 Free PMC article.

9

HE4 (WFDC2) gene overexpression promotes ovarian tumor growth.

Moore RG, Hill EK, Horan T, Yano N, Kim K, MacLaughlan S, Lambert-Messerlian G, Tseng YD, Padbury JF, Miller MC, Lange TS, Singh RK. Moore RG, et al. Among authors: kim k. Sci Rep. 2014 Jan 6;4:3574. doi: 10.1038/srep03574. Sci Rep. 2014. PMID: 24389815 Free PMC article.

10

HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation.

Lokich E, Singh RK, Han A, Romano N, Yano N, Kim K, Moore RG. Lokich E, et al. Among authors: kim k. Sci Rep. 2014 Jun 30;4:5500. doi: 10.1038/srep05500. Sci Rep. 2014. PMID: 24975515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,572 results

Search Page

Filters